1001395-19-2

Upstream product

• 123874-20-4 2-bromo-3-methyl-4-nitrophenol 
• 1001395-20-5 5-(benzyloxy)-4-bromo-1H-indole 
• 98-09-9 benzenesulfonyl chloride 

Downstream Products

• 1001392-26-2 4-[(3-hydroxypyrrolidin-1-yl)methyl]-1-(phenylsulfonyl)-1H-indol-5-ol 
• 1022951-65-0 2,4-dimethyl-8-(phenylsulfonyl)-1,3,4,8-tetrahydro-2H-[1,4]oxazepino[6,7-e]indole 
• 1022951-62-7 2,5-methylene-9-(phenylsulfonyl)-1,2,3 ,4,5,9-hexahydro[1,5]oxazocino[3,2-e]indole 
• 1022951-70-7 2-isopropyl-8-(phenylsulfonyl)-1,3,4,8-tetrahydro-2H-[1,4]oxazepino[6,7-e]indole 
• 1022951-74-1 2-ethyl-8-(phenylsulfonyl)-1,3,4,8-tetrahydro-2H-[1,4]oxazepino[6,7-e]indole 

Relevant academic research and scientific papers

INDOLES AS 5-HT6 MODULATORS

The present invention relates to novel compounds of formula (I) wherein m, n, R0, R1, R2, R3 and R4 are as described herein, to pharmaceutical compositions comprising the compounds, to processes for t

8-SULFONYL-L, 3, 4, 8-TETRAHYDR0-2H- [1, 4] OXAZEPINO [6, 7-E] INDOLE DERIVATIVES AND THEIR USE AS 5-HT6 RECEPTOR LIGANDS

The present invention relates to compounds of the formula (I) wherein A, X and R1 to R9 are as described herein; to pharmaceutical compositions comprising the said compounds; to processes for their preparation; and to the use of the compounds as medicaments against 5-HT6 receptor-related disorders.